Contact Us
  Search
The Business Research Company Logo
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report 2026
Published :July 2026
Pages :250
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report 2026

Global Outlook – By Product (Instruments, Reagents, Consumables), By Instruments (Standard PCR, RT-PCR, Digital PCR), By End User (Pharmaceutical And Biotechnology Industries, Clinical Diagnostics Labs And Hospitals, Academics And Research Organization) – Market Size, Trends, Strategies, and Forecast to 2030

Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Overview

• Polymerase Chain Reactions (PCR) Devices, Reagents And Uses market size has reached to $6.51 billion in 2025 • Expected to grow to $9.84 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Prevalence Of Infectious Diseases Fuels Growth In PCR Devices And Reagents Market • Market Trend: Revolutionizing Allergen Detection with Advanced Diagnostic Tools • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

Polymerase Chain Reaction (PCR) devices and reagents are designed to aid scientists in producing multiple copies of specific DNA segments. In PCR, a section of the genome to be amplified is chosen using short synthetic DNA fragments called primers, and the segment is subsequently amplified through numerous rounds of DNA synthesis. The main products of Polymerase Chain Reactions (PCR) devices and reagents are instruments, reagents, and consumables. An instrument is a tool or device for doing a particular kind of work. The instruments used are standard PCR, rt- PCR, and digital PCR. The various end-users are the pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, academics, and research organizations.
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Bar Graph

What Is The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Size and Share 2026?

The polymerase chain reactions (pcr) devices, reagents and uses market size has grown strongly in recent years. It will grow from $6.51 billion in 2025 to $6.97 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to infectious disease outbreaks, expansion of genomics research, growth in clinical diagnostics labs, covid-19 testing demand, adoption of molecular biology techniques.

What Is The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Growth Forecast?

The polymerase chain reactions (pcr) devices, reagents and uses market size is expected to see strong growth in the next few years. It will grow to $9.84 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to growth in personalized medicine, rising cancer diagnostics, expansion of genetic screening, increasing research funding, demand for rapid diagnostics. Major trends in the forecast period include rising demand for molecular diagnostics, expansion of infectious disease testing, increased adoption of real-time PCR, growth of research-based pcr applications, miniaturization of pcr instruments.
Research Expert

Book your 30 minutes free consultation with our research experts

Top Market Segments Chart For Polymerase Chain Reactions (Pcr) Devices, Reagents And Uses Market Showing Segment-Wise Market Share Distribution.

Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Segmentation

1) By Product: Instruments, Reagents, Consumables 2) By Instruments: Standard PCR, RT-PCR, Digital PCR 3) By End User: Pharmaceutical And Biotechnology Industries, Clinical Diagnostics Labs And Hospitals, Academics And Research Organization Subsegments: 1) By Instruments: Thermal Cyclers, Real-Time PCR Systems, Digital PCR Systems 2) By Reagents: Master Mixes, Primers And Probes, Enzymes, Nucleotides 3) By Consumables: PCR Tubes, PCR Plates, Seals And Films, Pipette Tips

What Is The Driver Of The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

The growing prevalence of infectious diseases is expected to propel the growth of the polymerase chain reactions (PCR) devices, reagents and uses market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, that can be transmitted directly or indirectly from one individual to another. The rate of infectious disease incidence is rising due to increased travel, which facilitates the rapid spread of pathogens across borders. Polymerase chain reaction (PCR) devices, reagents, and uses aid in infectious disease diagnosis by enabling rapid and accurate detection of pathogens. They improve laboratory efficiency by amplifying genetic material, allowing timely identification and effective management of infections. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the growing prevalence of infectious diseases is driving the growth of the polymerase chain reactions (PCR) devices, reagents and uses industry.

Key Players In The Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market

Major companies operating in the polymerase chain reactions (pcr) devices, reagents and uses market are Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc.
Top 10 Competitor Analysis And Market Overview Pie Chart For The Polymerase Chain Reactions (Pcr) Devices, Reagents And Uses Market

This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

Bubble Chart Of Company Scoring Matrix By Innovation, Brand And Revenue For The Polymerase Chain Reactions (Pcr) Devices, Reagents And Uses Market

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.

Explore how leading companies compare across key metrics in our report Get Report

What Are Latest Mergers And Acquisitions In The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

In June 2025, QIAGEN N.V., a Netherlands-based provider of molecular diagnostics solutions, partnered with Gencurix Inc. With this partnership, QIAGEN aims to develop multiplex oncology assays for tissue and liquid biopsies to broaden adoption of the QIAcuityDx digital PCR platform in clinical diagnostic laboratories. Gencurix Inc. is a South Korea-based molecular diagnostics company specializing in digital PCR assays and in vitro diagnostics.
Market Analysis Map Highlighting Largest Region For Polymerase Chain Reactions (Pcr) Devices, Reagents And Uses Market

Regional Outlook

North America was the largest region in the polymerase chain reactions (PCR) devices and reagents market in 2025. Western Europe was the second-largest region in the global polymerase chain reactions (PCR) devices and reagents market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
Need data for a specific geography? Request Regional Data

What Defines the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

The polymerase chain reactions (PCR) devices and reagents market consists of sales of conventional PCR machines, qPCR, reverse transcription PCR, nested PCR, hot start PCR, and digital PCR devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Market Attractiveness Scoring And Analysis Chart Evaluating Growth, Competition, Risk Factors For The Polymerase Chain Reactions (Pcr) Devices, Reagents And Uses Market

This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

Total Addressable Market Analysis Chart Displaying Revenue Potential And Market Size For The Polymerase Chain Reactions (Pcr) Devices, Reagents And Uses Market

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.

Access full TAM calculations and growth projections in our report Get Report

What Key Data and Analysis Are Included in the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report 2026?

The polymerase chain reactions (pcr) devices, reagents and uses market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reactions (pcr) devices, reagents and uses industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$6.97 billion
Revenue Forecast In 2030$9.84 billion
Growth RateCAGR of 9% from 2026 to 2030
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2030
Segments CoveredProduct, Instruments, End User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Key Companies ProfiledBio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us